These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 32299305)

  • 1. Sleeping Patterns in Patients with Opioid Use Disorder: Effects of Opioid Maintenance Treatment and Detoxification.
    Chrobok AI; Krause D; Winter C; Plörer D; Martin G; Koller G; Adorjan K; Canolli M; Adam R; Wagner EM; Peles E; Paul D; Vogel T; Pogarell O
    J Psychoactive Drugs; 2020; 52(3):203-210. PubMed ID: 32299305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of buprenorphine/naloxone maintenance treatment on sexual dysfunction, sleep and weight in opioid use disorder patients.
    Baykara S; Alban K
    Psychiatry Res; 2019 Feb; 272():450-453. PubMed ID: 30611963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency and correlates of sleep disturbance in methadone and buprenorphine-maintained patients.
    Dunn KE; Finan PH; Andrew Tompkins D; Strain EC
    Addict Behav; 2018 Jan; 76():8-14. PubMed ID: 28735039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insomnia and excessive daytime sleepiness in women and men receiving methadone and buprenorphine maintenance treatment.
    Hallinan R; Elsayed M; Espinoza D; Veillard AS; Morley KC; Lintzeris N; Haber P
    Subst Use Misuse; 2019; 54(10):1589-1598. PubMed ID: 31131668
    [No Abstract]   [Full Text] [Related]  

  • 5. Assessment of Subjective Sleep Problems in Men With Opioid Dependence Maintained on Buprenorphine.
    Tripathi R; Dhawan A; Rao R; Mishra AK; Jain R; Sinha S
    J Addict Med; 2020; 14(2):132-138. PubMed ID: 30964756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous Misuse of Methadone, Buprenorphine and Buprenorphine-Naloxone in Patients Under Opioid Maintenance Treatment: A Cross-Sectional Multicentre Study.
    Lugoboni F; Zamboni L; Cibin M; Tamburin S;
    Eur Addict Res; 2019; 25(1):10-19. PubMed ID: 30625491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors Associated with Sleep Disorders among Methadone-Maintained Drug Users in Vietnam.
    Le TA; Dang AD; Tran AHT; Nguyen LH; Nguyen THT; Phan HT; Latkin CA; Tran BX; Ho CSH; Ho RCM
    Int J Environ Res Public Health; 2019 Nov; 16(22):. PubMed ID: 31698771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High prevalence of constipation and reduced quality of life in opioid-dependent patients treated with opioid substitution treatments.
    Lugoboni F; Mirijello A; Zamboni L; Faccini M; Casari R; Cossari A; Gasbarrini A; Addolorato G; On Behalf Of Gics
    Expert Opin Pharmacother; 2016 Nov; 17(16):2135-2141. PubMed ID: 27603712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Constipation and other common symptoms reported by women and men in methadone and buprenorphine maintenance treatment.
    Haber PS; Elsayed M; Espinoza D; Lintzeris N; Veillard AS; Hallinan R
    Drug Alcohol Depend; 2017 Dec; 181():132-139. PubMed ID: 29054032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sleep-disordered breathing in patients with opioid use disorders in long-term maintenance on buprenorphine-naloxone: A case series.
    DeVido J; Connery H; Hill KP
    J Opioid Manag; 2015; 11(4):363-6. PubMed ID: 26312963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delayed villous maturation in term placentas exposed to opioid maintenance therapy: a retrospective cohort study.
    Serra AE; Lemon LS; Mokhtari NB; Parks WT; Catov JM; Venkataramanan R; Caritis SN
    Am J Obstet Gynecol; 2017 Apr; 216(4):418.e1-418.e5. PubMed ID: 28024988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dissatisfaction with opioid maintenance treatment partly explains reported side effects of medications.
    Muller AE; Bjørnestad R; Clausen T
    Drug Alcohol Depend; 2018 Jun; 187():22-28. PubMed ID: 29626742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of bundling medication-assisted treatment for opioid addiction with mHealth: study protocol for a randomized clinical trial.
    Gustafson DH; Landucci G; McTavish F; Kornfield R; Johnson RA; Mares ML; Westergaard RP; Quanbeck A; Alagoz E; Pe-Romashko K; Thomas C; Shah D
    Trials; 2016 Dec; 17(1):592. PubMed ID: 27955689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can patients receiving opioid maintenance therapy safely drive? A systematic review of epidemiological and experimental studies on driving ability with a focus on concomitant methadone or buprenorphine administration.
    Strand MC; Fjeld B; Arnestad M; Mørland J
    Traffic Inj Prev; 2013; 14(1):26-38. PubMed ID: 23259516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Breast feeding during methadon- and buprenorphin therapy].
    Müller MJ; Lange M; Paul T; Seeliger S
    Klin Padiatr; 2011 Dec; 223(7):408-13. PubMed ID: 21969026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Buprenorphine or methadone for detoxification of young opioid addicts?].
    Ebner R; Schreiber W; Zierer C
    Psychiatr Prax; 2004 Nov; 31 Suppl 1():S108-10. PubMed ID: 15570521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of efficacy between buprenorphine and tramadol in the detoxification of opioid (heroin)-dependent subjects.
    Chawla JM; Pal H; Lal R; Jain R; Schooler N; Balhara YP
    J Opioid Manag; 2013; 9(1):35-41. PubMed ID: 23709302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug safety and adverse drug reaction reporting behavior related to outpatient opioid replacement therapy: Results from a survey among physicians.
    Gahr M; Eller J; Cabanis M; Hiemke C; Freudenmann RW; Connemann BJ; Lang D; Schönfeldt-Lecuona C
    J Subst Abuse Treat; 2017 Mar; 74():7-15. PubMed ID: 28132703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between sleep and opioids in chronic pain patients.
    Frers A; Shaffer J; Edinger J; Wachholtz A
    J Behav Med; 2021 Jun; 44(3):412-420. PubMed ID: 33609232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Actigraphic measurements in opioid detoxification with methadone or buprenorphine.
    Pjrek E; Frey R; Naderi-Heiden A; Strnad A; Kowarik A; Kasper S; Winkler D
    J Clin Psychopharmacol; 2012 Feb; 32(1):75-82. PubMed ID: 22198453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.